Author

T. Abdelaal

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell-cell communication· 1 Assay:CITE-seq· 1 Approach:deep learning· 1 Research Focus:differential expression· 1

Frequent Co-Authors

E. Beyranvand Nejad· 2 shared E. T. I. van der Gracht· 2 shared F. Ossendorp· 2 shared G. Beyrend· 2 shared K. L. M. C. Franken· 2 shared R. Arens· 2 shared S. van Duikeren· 2 shared T. C. van der Sluis· 2 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

E. Beyranvand Nejad

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Integration of Mass Cytometry and Mass Spectrometry Imaging for Spatially Resolved Single Cell Metabolic Profiling

J. B. Nunes, M. E. Ijsselsteijn, T. Abdelaal, R. Ursem, M. van der Ploeg, B. Everts, A. Mahfouz, B. Heijs, N. de Miranda

The paper integrates mass cytometry and mass spectrometry imaging to analyze metabolic heterogeneity in tissues and its link to cell populations like cancer and immune cells.

bioRxiv · Aug 29, 2023Cancer Biology

OX40 agonism enhances efficacy of PD-L1 checkpoint blockade by shifting the cytotoxic T cell differentiation spectrum

G. Beyrend, T. C. van der Sluis, E. T. I. van der Gracht, T. Abdelaal, S. P. Jochems, R. A. Belderbos, T. H. Wesselink, S. van Duikeren, F. J. van Haften, A. Redeker, E. Beyranvand Nejad, M. Camps, K. L. M. C. Franken, M. M. Linssen, P. Hohenstein, , R. Arens

This study shows that OX40 agonism improves PD-L1 checkpoint blockade by altering T cell differentiation, leading to enhanced anti-tumor immunity through dynamic expression of NK and chemokine receptors.

bioRxiv · Dec 24, 2021 · PreprintImmunology

A third vaccination with a single T cell epitope protects against SARS-CoV-2 infection in the absence of neutralizing antibodies

I. N. Pardieck, E. T. I. van der Gracht, D. M. B. Veerkamp, F. M. Behr, S. van Duikeren, G. Beyrend, J. Rip, R. Nadafi, T. C. van der Sluis, E. Beyranvand Nejad, N. Mulling, D. J. Brasem, M. G. M. Camps, S. K. Myeni, P. J. Bredenbeek, , R. Arens

A third dose of a single T cell epitope vaccine protects mice from SARS-CoV-2 infection without neutralizing antibodies by enhancing effector-memory and tissue-resident memory T cells.

bioRxiv · Dec 15, 2021 · PreprintImmunology